Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,045 | -20,520 | -39,171 | -46,425 | -11,087 |
| Depreciation Amortization | 429 | 387 | 25,243 | 36,059 | 135 |
| Income taxes - deferred | N/A | N/A | -6,150 | -2,617 | 0 |
| Accounts receivable | -3,589 | 2,441 | 344 | -1,949 | 131 |
| Accounts payable and accrued liabilities | 594 | -355 | 243 | -2,624 | 854 |
| Other Working Capital | -4,512 | 1,761 | 6,980 | -8,691 | 1,116 |
| Other Operating Activity | 21,817 | 6,684 | 3,121 | 6,033 | 2,498 |
| Operating Cash Flow | $-34,306 | $-9,602 | $-9,389 | $-20,214 | $-6,353 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -71,883 | -28,257 | 0 | N/A | N/A |
| PPE Investments | -204 | -1 | -961 | -105 | -125 |
| Net Acquisitions | N/A | N/A | N/A | 13,685 | N/A |
| Purchase Sale Intangibles | -139 | -28 | -40 | -54 | -96 |
| Other Investing Activity | -138 | -28 | -40 | 146 | -96 |
| Investing Cash Flow | $-72,226 | $-28,286 | $-1,001 | $13,726 | $-221 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 632 | N/A | N/A | N/A | 1 |
| Common Stock Issued | 213,487 | 12,699 | 37,426 | 17 | 2 |
| Other Financing Activity | -632 | -167 | -4,936 | 15,825 | 4,980 |
| Financing Cash Flow | $213,487 | $12,532 | $32,490 | $15,841 | $4,983 |
| Exchange Rate Effect | N/A | N/A | -50 | 74 | -172 |
| Beginning Cash Position | 8,997 | 34,353 | 12,304 | 2,876 | 4,639 |
| End Cash Position | 115,952 | 8,997 | 34,353 | 12,304 | 2,876 |
| Net Cash Flow | $106,955 | $-25,356 | $22,050 | $9,428 | $-1,763 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,306 | -9,602 | -9,389 | -20,214 | -6,353 |
| Capital Expenditure | -204 | -1 | -975 | -112 | -125 |
| Free Cash Flow | -34,510 | -9,603 | -10,364 | -20,327 | -6,478 |